Hospital Acquired Infection Control Market

Market Study on Hospital Acquired Infection Control: Demand from Ambulatory Surgical & Diagnostic Centers to Rise Rapidly

Hospital Acquired Infections Control Market Segmented By Moist Heat Sterilization Equipment, Dry Heat Sterilization Equipment, Low Temperature Sterilization Equipment, Radiation Sterilization Equipment, Disinfection Equipment with Washer Disinfector, Flusher Disinfector

  • November-2021
  • PMRREP2814
  • 201 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Market Snapshot

Recently updated analysis on the global hospital acquired infection control market reveals that the market was worth US$ 5.5 Bn in 2020 and is predicted expand 1.6X by 2031, rising at a steady CAGR of 5% over the decade. As a result, the market for hospital acquired infection control equipment is anticipated to be valued at around US$ 9 Bn by 2031. Sales of hospital acquired infection control systems account for around 13% of the global infection control market, which was valued at US$ 42 Bn in 2020.

Hospital Acquired Infection Control Market Value in 2020

US$ 5.5 Bn

Hospital Acquired Infection Control Equipment Sales Forecast for 2031

US$ 9 Bn

Market CAGR (2021-2031)

5%

North America Market Revenue Share in 2020

30%

Find Out More about the Report Coverage

Companies

Company Profile

  • Olympus Corporation
  • Medivators Inc. (Cantel Medical Corp.)
  • Getinge Group
  • STERIS Plc.
  • Belimed AG (Metall Zug)
  • Steelco S.P.A
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • Merck & Co., Inc.
  • Advanced Sterilization Products Services Inc. (Johnson & Johnson)
  • Abbott Laboratories
  • Bayer AG
  • Alere Inc.
  • The 3M Company
  • Cepheid Inc
  • Others

Demand Analysis of Hospital Acquired Infection Control Equipment from 2016 to 2020 Vs Market Outlook for 2021 to 2031

Healthcare infrastructure has evolved a lot over the past decade as the proliferation of technology increased and the adoption of innovative medical devices saw a rise. Need for disinfection and sterilization equipment has become more prominent than ever before as the prevalence of various infectious and chronic diseases rose in the past decade. As such, the market for hospital acquired infection control equipment accounted for a net worth of US$ 5.5 Bn in 2020.

Demand for hospital acquired infection control technology is expected to be driven by factors such as rising awareness about healthcare-associated infections, government initiatives to fortify infection control systems across various medical institutions, and rising incidence of infectious and contagious diseases. Sales of hospital acquired infection control equipment are predicted to advance at a CAGR of 5% through 2031.

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Will Rising Awareness about Personal Hygiene Drive Demand for Hospital Acquired Infection Control Equipment?

Personal hygiene has seen a complete reboot after the COVID-19 pandemic that struck the world in 2020. Focus on personal care grew exponentially in the pandemic era, and demand for and hand hygiene equipment is expected to be high the post-pandemic era as well.

Infection prevention was the key focus and has fuelled the hygiene market throughout 2020, and is expected to maintain a similar pace through the decade.

Increasing instances of nosocomial infections have also led to a paradigm shift in personal hygiene trends. Rising awareness among the general population about infections is expected to benefit the hospital acquired infection control industry as healthcare institutions would be seeing high demand from people to put in place effective inflection control measures.

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

How Will Rise in Surgical Procedures Impact Sales of Hospital Acquired Infection Control Equipment?

Globally, the number of surgical procedures performed every year has been increasing substantially and is expected to reach a new high by the end of the decade. The risk of healthcare-associated infections is also predicted to rise as demand for surgical instruments increases with rising number of surgical procedures performed.

Rising awareness about the effectiveness of sterilised and disinfected medical instruments and devices is a key factor that will help propel demand for nosocomial infection control equipment. Increasing prevalence of chronic diseases and rising advancements in surgical equipment are other factors that will drive sales of hospital acquired infection control systems.

Explore Persistence Market Research’s expertise in promulgation of the business !

What Could Restrain the Adoption of Hospital Acquired Infection Control Systems?

The procedures and methods for hospital acquired infection control have been termed as complex, and this is true for the most part, as it requires the use of advanced techniques and devices. Some medical devices such as endoscopes are more important to be sterilized as inconsistency in them could risk nosocomial infections, which could cause further complications in patients.

Sterilization and disinfection systems have substantially changed and advanced over the years, but there is still a lack of these services that would ensure the safety of reprocessed devices that are being used. The trend of reprocessing equipment is a major challenge regarding hospital acquired infection control, which could potentially slow down market growth to some extent.

hospital-acquired-infections-control-market

Country-wise Analysis

How is Demand for Hospital Acquired Infection Control Shaping Up in the U.S.?

The U.S. is an extremely lucrative market for hospital acquired infection control equipment. The nation has a robust healthcare infrastructure that is always improving. Demand for infection control in the U.S. is driven by huge healthcare expenditure and high awareness among the general population regarding infection control. In the North American region, the U.S. is expected to bring in majority of revenue.

Why Should Hospital Acquired Infection Control Equipment Suppliers Focus on India?

India is the second-most populated nation in the world, and with such a huge population, there is immense scope for the healthcare industry in the country. The nation is a developing one and healthcare infrastructure is still being developed, which makes it a very lucrative market for key manufacturers of hospital acquired infection control equipment.

Disinfection equipment is expected to see significant demand in India as awareness regarding hygiene increases and focus on healthcare rises. Developments and advancements in healthcare infrastructure in India are expected to pick pace over the decade, and this would prove highly beneficial for market players operating in the country.

Category-wise Analysis

What is the Outlook for Various End Use Applications of Hospital Acquired Infection Control Equipment?

The hospitals segment is predicted to witness the most prominent demand for hospital acquired infection control systems, and is expected to account for a dominant revenue share as it did back in 2020, at nearly 45%.

Meanwhile, use of hospital acquired infection control systems at ambulatory surgical and diagnostic centers is expected to rise at a high CAGR over the forecast period.

COVID-19 Pandemic Impact Analysis

In 2020, the world was hit by the worst infectious disease that it had seen in decades. The infection of coronavirus hit the world at a level that was never imagined or expected, and the spread was also partially driven by hospital acquired infections as there were inadequate measures in place. Many medical professionals were also affected by COVID-19 and most of those cases were due to contact and infections spread via hospital environments.

When the severity of the pandemic was realized, focus on hospital acquired infections was substantially increased and many measures were put in place to curb them. This created massive demand in the hospital acquired infection control equipment. Demand for hospital acquired infection control devices is expected to see a drop as the pandemic subsides, but increasing focus on hospital acquired infections is expected to keep the market afloat at a modest rate over the coming years.

Competitive Landscape

The healthcare industry has seen some major changes in the past few years, and healthcare-associated infections have gained a lot of attention due to a rise in their instances. Key players are trying to maximize their market potential with new launches and fortifying their research & developments to gain an edge over their competitors.

  • In April 2020, when the COVID-19 pandemic was peaking, demand for disinfection was more than ever. Allegheny Health Network (AHN), amidst this, announced a sterilization process that would allow the reuse of N95 masks that were very crucially in demand.
  • In July 2021, UVision360 Inc. announced that it had received approval for the expansion of reprocessing procedures for utilization with the LUMINELLE DTx System.

Hospital Acquired Infection Control Industry Report Scope

Attribute

Details

Forecast Period

2021-2031

Historical Data Available for

2016-2020

Market Analysis

US$ Mn for Value

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • APEJ
  • MEA

Key Countries Covered

  • United States
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • Turkey
  • South Africa
  • GCC Countries

Key Market Segments Covered

  • Product Type
  • End User
  • Region

Key Companies Profiled

  • Olympus Corporation
  • Medivators Inc. (Cantel Medical Corp.)
  • Getinge Group
  • STERIS Plc.
  • Belimed AG (Metall Zug)
  • Steelco S.P.A
  • Pfizer Inc.
  • F. Hoffmann-La Roche Ltd
  • Merck & Co. Inc.
  • Advanced Sterilization Products Services Inc. (Johnson & Johnson)
  • Abbott Laboratories
  • Bayer AG
  • Alere Inc.
  • The 3M Company
  • Cepheid Inc.

Pricing

Available upon Request

Key Segments Covered in Hospital Acquired Infection Control Industry Survey

By Product Type:

  • Heat Sterilization Equipment
    • Moist Heat Sterilization Equipment
    • Dry Heat Sterilization Equipment
  • Low Temperature Sterilization Equipment
  • Radiation Sterilization Equipment
  • Disinfection Equipment
    • Washer Disinfectors
    • Flusher Disinfectors
  • Endoscopic Reprocessor Systems
    • Single Basin Endoscopic Reprocessor Systems
    • Dual Basin Endoscopic Reprocessor Systems
  • Disinfectants

By End User:

  • Hospital Acquired Infection Control Equipment for Hospitals
  • Hospital Acquired Infection Control Equipment for Ambulatory Surgical Centers
  • Hospital Acquired Infection Control Equipment for Diagnostic Laboratories
  • Hospital Acquired Infection Control Equipment for Clinics
  • Hospital Acquired Infection Control Equipment for Medical Institutions

Media Release

- FAQs -

The global hospital acquired infection control market was worth US$ 5.5 Bn in 2020.

In 2020, North America held a dominant market revenue share of 30% in the global market for hospital acquired infection control.

By the end of 2031, the market is estimated to be worth approximately US$ 9 Bn.

Demand for hospital acquired infection control systems is anticipated to rise at a CAGR of around 5% through 2031.

The APAC market is slated to rise at the highest CAGR over the next ten years.

The disinfection equipment segment is expected to be the most lucrative for industry participants over the coming years.

Key market players are Getinge Group, STERIS Plc., Belimed AG (Metall Zug), Steelco S.P.A, Pfizer Inc., F. Hoffmann-La Roche Ltd, and Merck & Co., Inc., who have been profiled in detail in this market analysis.

Recommendations

Infection Surveillance Solutions Market

Global infection surveillance solution market to increase from more than US$ 300 Mn in 2017 to about US$ 905 Mn by 2025 end, representing a CAGR of 14.04% from 2017-2025.

Perineal Care Market

Perineal Care Market is expected to register a CAGR of 4.6% from 2017 to 2025. In 2017, the marker was worth US$ 878.2 Mn and it is expected to reach a valuation of US$ 1,254.8 Mn by the end of 2025..

Infectious Diseases Diagnostics Market

Global market will reach a value worth US$ 876.6 Mn by 2016 end, up from US$ 827.7 Mn attained in 2015. The revenues are expected to reach US$ 1503.8 Mn by the end of 2024.

Prepackaged Medical Kits Trays Market

The global market for pre-packaged medical kits and trays is anticipated to showcase a stellar CAGR of 8.3% during the forecast period, reaching a market value of over US$ 29,000 Mn by the end of 2026..

Our Clients

Our Clients